Improving the “wait and see” approach to treatment for high-risk blood cancer
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.
- Myelodysplastic syndromes
- Research
Month: September 2017
“I needed two transfusions to make my daughter’s wedding”
Des says he owes his life to a clinical trial for the drug venetoclax.
- Chronic lymphocytic leukaemia
Anthony’s grateful family honours his memory with gift
The Leukaemia Foundation has thanked the Mammino and Puglisi families for their incredibly generous $10,000 gift.
- Our supporters
- Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador
- Talking Blood Cancer: Mother-Daughter Cancer Warriors
- The biggest challenge of cancer patients that nobody talks about…
- Physiotherapist and lymphoma survivor Julie Allen on cancer related fatigue
- Unlocking the Mysteries of Blood Cancer